Daniel LeSueur
Known title: Chief Operating OfficerCIK: 0002013388
Associated companies
Transaction History
| HCAT | ▼ Sell | Tax Withholding | 3,663 | $12K | 9/2/2025 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 3,802 | $14K | 6/2/2025 | View on chart |
| HCAT | ▼ Sell | Open Market | 5,209 | $21K | 5/5/2025 | View on chart |
| HCAT | ▼ Sell | Open Market | 5,209 | $22K | 4/3/2025 | View on chart |
| HCAT | ▼ Sell | Open Market | 16,902 | $76K | 3/5/2025 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 9,232 | $42K | 3/3/2025 | View on chart |
| HCAT | ▲ Buy | Grant | 11,340 | $0 | 2/20/2025 | View on chart |
| HCAT | ▲ Buy | Grant | 145,000 | $0 | 2/20/2025 | View on chart |
| HCAT | ▼ Sell | Open Market | 5,209 | $30K | 2/5/2025 | View on chart |
| HCAT | ▼ Sell | Open Market | 5,209 | $39K | 1/6/2025 | View on chart |
| HCAT | ▼ Sell | Open Market | 22,773 | $175K | 12/4/2024 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 10,455 | $94K | 12/1/2024 | View on chart |
| HCAT | ▼ Sell | Open Market | 5,209 | $40K | 11/5/2024 | View on chart |
| HCAT | ▼ Sell | Open Market | 5,209 | $40K | 10/3/2024 | View on chart |
| HCAT | ▼ Sell | Open Market | 8,137 | $62K | 9/4/2024 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 1,761 | $13K | 9/3/2024 | View on chart |
| HCAT | ▼ Sell | Open Market | 5,209 | $32K | 8/5/2024 | View on chart |
| HCAT | ▼ Sell | Open Market | 5,208 | $32K | 7/3/2024 | View on chart |
| HCAT | ▼ Sell | Open Market | 11,923 | $80K | 6/6/2024 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 1,873 | $12K | 6/3/2024 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 3,279 | $26K | 3/1/2024 | View on chart |
| HCAT | ▲ Buy | Grant | 70,000 | $0 | 3/1/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Health Catalyst Included in List of Unprofitable Stocks
Health Catalyst was recently named in a Yahoo Finance article listing unprofitable stocks that may fall short of expectations. The company currently trades near its support level, with an average analyst target of $1.77. This context highlights the ongoing focus on the company's profitability and valuation relative to its peers.
Health Catalyst Included in List of Unprofitable Stocks. Health Catalyst was recently named in a Yahoo Finance article listing unprofitable stocks that may fall short of expectations. The company currently trades near its support level, with an average analyst target of $1.77. This context highlights the ongoing focus on the company's profitability and valuation relative to its peers.